SCHEMBL4459744

SCHEMBL4459744

O=C(O)C1CCN(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089943 0.86 ALDH1A1 (0.50)
SCHEMBL5197245 0.84 TSHR (0.46)
SCHEMBL4441930 0.78
SCHEMBL19642625 0.78
SCHEMBL20467889 0.78
SCHEMBL21104938 0.76 ALDH1A1 (0.42)
SCHEMBL23546235 0.73
SCHEMBL2875954 0.73 NOTUM (0.46)
SCHEMBL11974085 0.73
SCHEMBL1661472 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3612822-B1 ESR TESTS OF METABOLIC CELL ACTIVITY AND ESR DEVICE THEREFOR NOXYGEN SCIENCE TRANSFER&DIAGNOSTICS GMBH (DE) 2024-10-02 EP disclosed
EP-3612822-A1 ESR TESTS OF METABOLIC CELL ACTIVITY AND ESR DEVICE THEREFOR Noxygen Science Transfer&Diagnostics GmbH (DE) 2020-02-26 EP disclosed
US-10202342-B2 Targeted delivery of imaging probes for in vivo cellular imaging UNIVERSITY OF MARYLAND, BALTIMORE (US) 2019-02-12 US disclosed
US-20090311236-A1 Therapeutic Peptide Compositions And Methods Of Making And Using Same IMMUNE @WORK, INC. (US) 2009-12-17 US disclosed